Related by context. Frequent words. (Click for all words.) 79 Presents Positive 78 Completes Enrollment 78 Patient Enrollment 75 Q2 Loss Narrows 75 Drug Candidate 74 FDA Accepts 74 Q2 Loss Widens 74 Announces Initiation 74 Preclinical Data 74 Q4 Loss Narrows 73 Phase III Clinical Trial 73 Clinical Trial Results 73 Generic Version 73 Initiates Phase 73 Q1 Loss Narrows 73 Q3 Loss Narrows 73 Cholesterol Drug 73 FDA Clears 73 Q1 Loss Widens 73 Inc Therapeutic Competitors 72 Announces Presentation 72 Pivotal Phase III 72 Q3 Loss Widens 72 Q4 Loss Widens 72 Pivotal Phase 72 Phase III Trial 72 Achieves Milestone 72 Initiate Phase 71 RNAi Therapeutics 71 Patent Covering 70 Regains Compliance 70 4Q Loss Widens 70 Shareholder Lawsuit 70 Regains Compliance With 70 Metastatic Melanoma 70 Completes Tender Offer 70 Vertex Pharmaceuticals Announces 70 Receives Patent 70 Reduces Risk 69 Blood Thinner 69 Significantly Reduces 69 Extends Tender Offer 69 Stockholders Approve Merger 69 Receives FDA Clearance 69 Posts Wider Loss 69 Explore Strategic Alternatives 69 Provides Guidance 68 Small Molecule 68 Secures Additional 68 Annual Meeting Date 68 Patent Lawsuit 68 Reports Positive 68 Well Tolerated 68 Announces Positive 68 Inc. Nasdaq IMGN 68 Awarded Patent 68 Q2 Profit Surges 68 Receives Notice 68 Net Loss Widens 67 Recombinant Human 67 Pivotal Trial 67 Prostate Cancer Patients 67 Lowers Guidance 67 Anti Inflammatory 67 Updates Guidance 67 Announces Publication 67 Announces Organizational Changes 67 Stock Soars 67 CFO Resigns 67 Shares Soar 66 Previously Announced 66 Announces Successful Completion 66 Cervical Cancer Vaccine 66 Monoclonal Antibody 66 Q4 Profit Surges 66 Announces Definitive Agreement 66 Patent Issued 66 Inc. NASDAQ TRGT 66 Files Patent 66 Issues Guidance 66 DYAX 66 Smallpox Vaccine 66 Pulmonary Arterial Hypertension 66 4Q Loss Narrows 66 FDA Warns 66 Shows Promise 66 ENZN 66 Calls Purchased 66 Provides Comprehensive 66 Q3 Profit Surges 66 Receives Positive 66 Q4 Profit Declines 66 Advanced Prostate Cancer 66 Study Demonstrates 66 Complete Merger 65 Positive Opinion 65 Patent Infringement Lawsuit 65 Skymark Research Initiates Independent 65 Discontinues 65 Q2 Profit Declines 65 Cancer Treatments